The U.S. Department of Justice (DOJ) collected $5.6 billion in False Claims Act recoveries in fiscal year (FY) 2021.
That is over twice as much as 2020, and a record 90 percent of the total was collected from the health care and life sciences industries.
DOJ’s health care recoveries in government-initiated actions were also more than double the total recoveries in actions initiated by whistleblowers.
Health care enforcement targeted:
- billing for unnecessary medical services,
- solicitation or payment of kickbacks for goods or services paid for by federal health care programs, and
- risk adjustment fraud related to Medicare Advantage programs.
The record-breaking year in FY 2021 shows that the pandemic has not weakened enforcement activity, especially for the health care and life sciences industries. Comprehensive and effective compliance is more important now than ever.
To dive deeper into these stats and their impact on health care companies, read more from attorneys George Breen, Erica Sibley Bahnsen, Daniel Fundakowski, and Elizabeth Harris:
About Thought Leaders in Health Law
The Thought Leaders in Health Law® video series tracks the latest trends in multiple areas of the health care and life sciences industries, featuring attorneys and advisors from Epstein Becker Green and EBG Advisors.
Trouble viewing this video? Please contact us at thisweek@ebglaw.com and mention whether you were at home or working within a corporate network. We'd also love to hear your suggestions for future episode topics.
THOUGHT LEADERS IN HEALTH LAW® is a registered trademark of Epstein Becker & Green, P.C.
People
- Board of Directors / Member of the Firm
- Member of the Firm
- Member of the Firm
- Member of the Firm